Drug Regulation and Incentives for Innovation: The case of Asean

Sauwakon Ratanawijitrasin, Ph.D.

The focus of this paper is to examine the ways in which regulatory frameworks affect the incentives for pharmaceutical innovations in developing countries, using member countries of the Association of South-east Asian Nations ( ASEAN) as a case study.

Share